Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus Limbal Relaxing Incision (LRI) Patients

Phase 4

Withdrawn

• Conditions: Cataracts
• Interventions: Device: Toric; Procedure: Limbal Relaxing Incision

• Registration Number: NCT00929747
• Lead Sponsor: Alcon Research

Brief Summary

A prospective evaluation of postoperative corneal aberrations and visual parameters in patients assigned to either an AcrySof IQ Toric intraocular lens (IOL) group or a group implanted with a SN60WF IOL and having concomitant limbal relaxing incision.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2009-06
• Study First Submitted: 2009-06-25
• Study First Submitted QC: 2009-06-26
• Study First Posted: 2009-06-29
• Status Verified: 2009-10
• Primary Completion: 2009-10
• Study Completion: 2009-10
• Last Update Submitted: 2012-04-10
• Last Update Posted: 2012-04-12

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. operable cataracts
2. good ocular health
3. 0.5 D to 2.0 D of corneal astigmatism

Read More

Exclusion Criteria

1. > 2.0 D astigmatism
2. irregular astigmatism
3. prior or ongoing corneal disease or scarring
4. history of ocular disease

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Toric IOL	Toric	AcrySof IQ Toric IOL
Limbal Relaxing Incision	Limbal Relaxing Incision	AcrySof IQ with Limbal Relaxing Incision

Primary Outcome Measures

Name	Time	Method
Corneal aberration	3 months

Secondary Outcome Measures

Name	Time	Method
Visual acuity	3 months

Trial Locations

Locations (1)

Alcon Call Center for Trial Locations; 🇺🇸 Fort Worth, Texas, United States